The DOI matches its Crossref record; 168 of the 176 references it cites were found in a registry or an index.
Can herbs provide a new generation of drugs for treating Alzheimer’s disease?
Abstract
The overall aim of this review is to discuss cellular mechanisms at work in the progression of AD and current therapeutic strategies for treating AD, with a focus on the potential efficacy of herbal treatments. Recent advances in molecular, cellular, and animal model studies have revealed that formation of the 4-kDa amyloid beta peptide is a key factor in the development and progression of AD. Several cellular changes have been identified that are related to amyloid beta plaques and neurofibrillary tangles found in the autopsied brains of AD patients and in AD animal models. Several therapeutic strategies have been developed to treat AD, including anti-inflammatory, anti-oxidant, and anti-amyloid approaches. Recently, herbal treatments have been tested in animal and cellular models of AD and in clinical trials with AD subjects. In AD animal models and cell models, herbal extracts appear to have fewer adverse effects than beneficial effects on A beta and cognitive functions. These extracts have multi-functional properties (pro-cholinergic, anti-oxidant, anti-amyloid, and anti-inflammatory), and their use in the treatment of AD patients looks promising. The chemical compositions of herbs and their potential for alleviating or reducing symptoms of AD or for affecting the disease mechanism need to be further studied.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The worldwide increasing tendency toward using phytochemicals may be due to low toxicity, and synergistic effects [199,200,201].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [199]
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Rémésy, C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.230s · Cited by 4,219
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Flavonoids: a review of probable mechanisms of action and potential applications.
Nijveldt, R., van Nood, E., van Hoorn, D. V., Boelens, P., van Norren, K., & van Leeuwen, P. V. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.418 · Cited by 3,232
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Flavonoids: antioxidants or signalling molecules?
Williams, R. J., Spencer, J. P. E., & Rice-Evans, C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.001 · Cited by 2,016
Flagged first, then by citations
8 of the 176 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Reddy, 2005, Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant mouse models, Neurobiol. Aging.
Cited by
Sorted by citations
Items 101–139 of 139
Potbhare, M. S., Barik, R., & Khobragade, D. S. (2023) · Journal of Young Pharmacists · doi:10.5530/097515050344 · Cited by 7
Melissa officinalis (lemon balm)
Doukani, K., Selles, S. M. A., & Bouhenni, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819212-2.00047-5 · Cited by 8
The Benefits of Calorie Restriction and Calorie Restriction Mimetics as Related to the Eye
Anekonda, T. S. (2009) · Open Longevity Science · doi:10.2174/1876326x00903010028 · Cited by 7
Qader, S. W., Abdallah, H. H., Zahid, M., & Chua, L. S. (2020) · Journal of Theoretical and Computational Chemistry · doi:10.1142/s0219633620500297 · Cited by 6
Aegle marmelos (L.) Leaf Extract Improves Symptoms of Memory Loss Induced by Scopolamine in Rats
Thongsopha, C., Chaiwut, T., Thaweekhotr, P., Sudwan, P., Phasukdee, N., & Quiggins, R. (2024) · Foods · doi:10.3390/foods13040627 · Cited by 5
“Herbal medicines have various bioactive compounds that have been shown to benefit AD sufferers, as they are anti-inflammatories, antioxidants, and anti-amnesics [17,18].”
BackgroundPallàs, M., Sanfeliu, C., Pelegrı́, C., Cristòfol, R. M., Camins, A., Mercè, & Vilaplana, J. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch22 · Cited by 5
“A link between SIRT1 and Alzheimer’s disease (AD) is also becoming increasingly evident [44,45].”
BackgroundForskolin Ameliorates Scopolamine Induced Memory Impairment in Rats
Patole, A. M., Lamdhade, D., Dewani, S., Gandhare, B., & Raul, J. (2019) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2019.v05i12.008 · Cited by 4
“The condition is broadly visualized in elderly, and characterized by memory loss and many impairedcognitive functions [1].”
BackgroundSivaraman, D., Panneersel, P., & Muralidhar, P. (2016) · International Journal of Pharmacology · doi:10.3923/ijp.2016.52.65 · Cited by 4
In-Vitro Evaluation of Anticholinesterase and Antioxidant Activities of Cascuta Reflexa
Akhtar, M. S., Akbar, S., Erum, A., & Bhatti, S. A. (2019) · Journal of Herbs Spices & Medicinal Plants · doi:10.1080/10496475.2019.1579146 · Cited by 4
“Numerous herbal extracts capable of interacting with Aβ, mitochondrial antioxidant mechanisms, inflammatory pathways, and cholinergic and glutamergic functions in presynaptic and postsynaptic neurons have been identified (8).”
BackgroundResearch Advances on the Anti-aging Profile of Fructus lycii: an Ancient Chinese Herbal Medicine
Sze, S. C. W., Song, J., Chang, R. C., Zhang, K. Y., Wong, R. N., & Tong, Y. (2008) · Journal of Complementary and Integrative Medicine · doi:10.2202/1553-3840.1111 · Cited by 4
“the multifactorial characteristics of aging and looks promising in amelioration, prevention or treatment for aging and age-related diseases (Anekonda and Reddy 2005).”
BackgroundI J, O., S A, N., E E, E., F S, B., & E M, O. (2018) · International Journal of Pharmacology and Toxicology · doi:10.14419/ijpt.v6i2.13578 · Cited by 2
“Aromatherapy, non-pharmacological therapy, is currently used worldwide in the management of chronic pain, depression, anxiety as well as cognitive, sleep and stress–related disorders (Savelev et al., 2004; Anekonda and Reddy, 2005; Hritcu et al., 2012; Natarajan et al., 2013).”
BackgroundSrihari, S., Patel, K. S., & Rajagopala, S. (2012) · Cited by 2
Liu, J., Gao, X., & Wu, Y. (2008) · Neuroembryology and Aging · doi:10.1159/000193851 · Cited by 2
Isolation, structure characterization and quantification of related impurities in asperosaponin VI
Ji, D., Yun-Fei, L. I. U., Wang, Q.-H., Zhang, C., & Yang, Z. (2013) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(13)60063-1 · Cited by 2
Farooq, M. (2015) · International Journal of Agriculture and Biology · Cited by 2
Effects of Melissa officinalis on ethanol state-dependent learning in nicotine- treated mice
Ahmadi, R. (2016) · MOJ Anatomy & Physiology · doi:10.15406/mojap.2016.02.00030 · Cited by 2
Kohli, A., Kothiyal, P., Guru, S., C., R., & Nagar, P. (2015) · International journal of pharma research and review · Cited by 1
Measles from the Perspective of Rhazes and Traditional Iranian Medicine: a Narrative Review
Khodabakhsh, M., Mehri, M. R., Ghorbani, F., & Feyzabadi, Z. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22038/ijp.2016.7628 · Cited by 1
“Traditional and alternative medicine, have claimed an increasing share of the public’s awareness and the program of medical researchers in the past decades (12), and the believing that herbs are natural and hence safer than synthetic drugs, and that a complex mixture of herbs can effectively treat complex diseases is…”
BackgroundNatural Products in the Treatment of Alzheimer’s Disease
Obulesu, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816412-9.00004-5 · Cited by 1
Resíduos de romã (Punica granatum) na prevenção da doença de Alzheimer
Morzelle, M. C. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.11.2013.tde-21022013-104731 · Cited by 1
Xu, Y. (2011) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3rn37gs · Cited by 1
Nutraceuticals and Natural Product Derivatives in the Premises of Disease Prevention
Ullah, M. F., Bhat, S. H., & Abuduhier, F. M. (2018) · doi:10.1002/9781119436713.ch5 · Cited by 1
Monterrosas‐Brisson, N. (2010) · REMERI - Red Mexicana de Repositorios Institucionales
Hall, K. (2011) · ORCA Online Research @Cardiff (Cardiff University)
ReviewArticle Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment
Casadesús, G., Puig, E. R., Webber, K. M., Atwood, C., Castell, M., Bowen, R. L., Perry, G. L., Smith, M. A., Middleton, W. S., & Veterans, M. (2006)
Bhatia, T. N., Ghumatkar, P. J., & Sathaye, S. S. (2016) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-1105028797
“Thus there is a dire need for the discovery of drug molecules that could target other pathways involved in the pathogenesis of Alzheimer‘s disease (55).”
Backgroundde Asevedo, F. R., de Oliveira, M., Johanssy, de Oliveira, M. V., de Alencar, B., & de Freitas, R. M. (2014)
Synaptic Plasticity In Alzheimer’s Disease
Montoya, D. A. C. (2001) · Revista Neurociências · doi:10.34024/rnc.2011.v19.8331
Cognitive Enhancement and Neuroprotective Abilities of Plants
Mustafa, K., Kanwal, J., Khakwani, S., & Musaddiq, S. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-2094-9.ch007
Ghazali, M. I. (2019) · UTHM Institutional Repository (Universiti Tun Hussein Onn Malaysia)
Cognitive Enhancement and Neuroprotective Abilities of Plants
Mustafa, K., Kanwal, J., Khakwani, S., & Musaddiq, S. (2021) · IGI Global eBooks · doi:10.4018/978-1-6684-3546-5.ch011
Current awareness in human psychopharmacology
(2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.732
Current awareness in geriatric psychiatry
(2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1511
Wu, G., Wang, F., Zheng, N., Zhou, Q., Chen, Z., Chen, Z., Li, B., Ye, Q., & Li, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4834086/v1
Wu, G., Wang, F., Chen, Z., Zheng, N., Zhou, Q., Xie, L., Yang, X., Song, D., Sun, Q., Lin, J., et al. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.578886
Metadata
- Authors
- Anekonda, T. S., & Reddy, P. H.
- Affiliations
- Oregon Health & Science University (US)
- Corresponding author
- Reddy, P. Hemachandra
- Venue
- Brain Research Reviews
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 50
- Issue
- 2
- Pages
- 361-376
- ISSN
- 0165-0173 (ISSN-L)
- OpenAlex
- W1991124307
- Cited by
- 140
- References
- 176
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 11 · 2019: 12 · 2018: 8 · 2017: 6 · 2016: 9 · 2015: 8 · 2014: 10 · 2013: 10 · 2012: 6
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r03ag022643-01)
- National Institute on Aging (AG 22643)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, herbal medicine, amyloid-beta, amyloid plaques, neurofibrillary tangles, anti-amyloid therapy, anti-inflammatory therapy, antioxidant therapy, cognitive function, plant extracts, animal models of Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Animals, Antioxidants, Disease Models, Animal, Humans, Plant Extracts, Herbal Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
